In this application we propose to develop microRNA and ultraconserved non coding RNA (UCR) biomarkers for the assessment of cancer risk and for the early detection of five different epithelial cancers, including the four most common malignant tumors (lung, breast, prostate, and colorectal cancer). A major reason, if not the major reason, of why these common epithelial tumors cause so much death and fail to respond to treatment is that by the time they are detected and diagnosed, the malignant cells have accumulated a large number of genetic and epigenetic alterations and have often acquired a """"""""mutator"""""""" phenotype. During the past five years, we have established the microRNA expression profiles and, in some cases the UCR expression profiles, of the major human epithelial malignancies. On the basis of this extensive experience, now we intend to assess whether microRNA and UCR dysregulation can be detected in the serum of individuals at risk of developing cancer and at risk of cancer progression in order to develop non invasive biomarkers of cancer risk and for early detection. Such biomarkers could then be also exploited to follow the success of therapy.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project--Cooperative Agreements (U01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-C (M1))
Program Officer
Rinaudo, Jo Ann S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Ohio State University
Schools of Medicine
United States
Zip Code
Pekarsky, Yuri; Balatti, Veronica; Palamarchuk, Alexey et al. (2016) Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer. Proc Natl Acad Sci U S A 113:5071-6
Fong, Louise Y; Taccioli, Cristian; Jing, Ruiyan et al. (2016) MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency. Oncotarget 7:10723-38
Gaudio, Eugenio; Paduano, Francesco; Ngankeu, Apollinaire et al. (2016) A Fhit-mimetic peptide suppresses annexin A4-mediated chemoresistance to paclitaxel in lung cancer cells. Oncotarget 7:29927-36
Cataldo, Alessandra; Cheung, Douglas G; Balsari, Andrea et al. (2016) miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response. Oncotarget 7:786-97
Taccioli, Cristian; Garofalo, Michela; Chen, Hongping et al. (2015) Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. J Natl Cancer Inst 107:
Di Leva, Gianpiero; Cheung, Douglas G; Croce, Carlo M (2015) miRNA clusters as therapeutic targets for hormone-resistant breast cancer. Expert Rev Endocrinol Metab 10:607-617
Kim, Taewan; Jeon, Young-Jun; Cui, Ri et al. (2015) Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis. J Natl Cancer Inst 107:
Palmieri, Dario; Richmond, Timothy; Piovan, Claudia et al. (2015) Human anti-nucleolin recombinant immunoagent for cancer therapy. Proc Natl Acad Sci U S A 112:9418-23
Lee, Tae Jin; Haque, Farzin; Vieweger, Mario et al. (2015) Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor. Methods Mol Biol 1297:137-52
Cui, Ri; Kim, Taewan; Fassan, Matteo et al. (2015) MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7. Oncotarget 6:21802-15

Showing the most recent 10 out of 62 publications